Relationship of endometrial thickness with the menstrual timing of leuprolide acetate administration for preoperative preparation for hysteroscopic surgery.
OBJECTIVE
To assess the relationship of menstrual timing of administration of gonadotropin-releasing hormone (GnRH) agonist on the effectiveness of endometrial thinning and unwanted uterine bleeding.


METHODS
Prospective observational study.


METHODS
Gynecology department of a community hospital.


METHODS
One hundred consecutive women in a private practice, without submucous myomas, scheduled for transcervical endomyometrial resection or ablation.


METHODS
A GnRH agonist was administered at an unspecified time of the menstrual cycle. Transcervical hysteroscopic endomyometrial resection or ablation was performed 1 month later.


RESULTS
No significant statistical differences were seen in either the effectiveness of endometrial thinning or the occurrence or severity of unwanted uterine bleeding.


CONCLUSIONS
A GnRH agonist as pretreatment for endomyometrial resection or ablation can be administered at any time during the menstrual cycle with similar efficacy. Timing of surgery can be at the mutual convenience of patient and physician.
Nathanson
H G
HG
Department of Obstetrics and Gynecology, South Nassau Communities Hospital, Oceanside, New York, USA.
Phillips
D R
DR
Milim
S J
SJ
Haselkorn
J S
JS
Kapra
A
A
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004717:Endometrium / Q000187:drug effects / Q000473:pathology* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D007044:Hysterectomy; D016729:Leuprolide / Q000008:administration & dosage*; D008595:Menorrhagia / Q000601:surgery; D008598:Menstruation / Q000187:drug effects* / Q000502:physiology; D008875:Middle Aged; D019370:Observation; D011183:Postoperative Complications / Q000517:prevention & control; D011300:Preoperative Care / Q000379:methods; D011446:Prospective Studies; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide